吉贝尔：正在开展抗抑郁新药JJH201501、抗肿瘤新药JJH201601等创新型药物的研发工作

Core Viewpoint - The company emphasizes its diverse product range and ongoing research and development efforts to ensure long-term stable growth [1] Product Lifecycle and Pipeline Development - The company has a rich variety of products covering multiple therapeutic areas, with its main product, Likujun tablets, showing promising applications in the oral white blood cell-boosting drug sector [1] - The company is also developing innovative drugs such as the antidepressant JJH201501 and the anti-tumor drug JJH201601, supported by its research technology platforms including compound formulation, deuterated drug, and liposome drug development technologies [1]